Kris Kumar
Interventional Cardiology · Portland, ORNPI 1003294968
Payments from drug & device makers
What this record shows
This record is dominated by grants: $18,349 of the $21,694 with a category attached, or 84.6%. 16 manufacturers reported payments, led by Boston Scientific at 48.6% of the total. Reporting peaked in 2023 at $15,396 and has fallen 98.4% since, to $246 in 2025.
Across 46 payments — averaging $471.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$11K
- Medtronic$8K
- Abbott$2K
- Edwards Lifesciences$438
- Abiomed$196
- Terumo Medical Corporation$142
- plus $572 from 10 others
Across 2 payments — averaging $75.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abiomed$150
What the payments were for
- Grants$18,34985%
- Travel & lodging$1,2706%
- Food & beverage$1,9989%
- Education$760%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 5 | $10,539 |
| Medtronic | 3 | $8,044 |
| Abbott | 10 | $1,762 |
| Edwards Lifesciences | 9 | $438 |
| Abiomed | 6 | $196 |
| Terumo Medical Corporation | 1 | $142 |
| Shockwave Medical, Inc | 2 | $133 |
| Bard Peripheral Vascular, Inc. | 1 | $111 |
| Amgen | 1 | $90 |
| Chiesi USA, Inc. | 1 | $75 |
| W. L. Gore & Associates, Inc. | 2 | $43 |
| Stryker | 1 | $35 |
| Biotronik Inc. | 1 | $27 |
| Cook Medical LLC | 1 | $23 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $18 |
| Asahi Intecc USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RESOLUTE ONYX$4,000
- MitraClip$1,259
- GENERAL ATHERECTOMY$349
- SAPIEN 3 Ultra RESILIA$210
- AMPLATZER$163
- Azur CX Detachable$142
- Lutonix Drug Coated Balloon$111
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$107
- Edwards SAPIEN 3 Transcatheter Heart Valve$106
- WATCHMAN Access System$106
- Perclose ProGlide suture mediated closure system$106
How this compares
$21,694 in reported general payments places this provider in the 75th percentile of 68 interventional cardiology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $13,324 |
| ClopidogrelClopidogrel Bisulfate | 44 | $438 |
| Atorvastatin Calcium | 23 | $263 |
| Metoprolol Succinate | 13 | $119 |
| Furosemide | 12 | $69 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Portland
- Jason WollmuthPortland$749K
- Ethan KorngoldPortland$407K
- Amish DesaiPortland$186K
- Harsh GolwalaPortland$105K
- Brandon JonesPortland$101K
- Kathryn DawsonPortland$57K
- Logan VincentPortland$42K
- Amged AbdelazizPortland$38K
- Richard SohnPortland$38K
- Daniel FeldmanPortland$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.